Elevation Oncology Inc (ELEV)’s debt-to-equity and long-term debt/equity ratios

In other words, the price has increased by $0.0000 from its previous closing price. On the day, 1814421 shares were traded. ELEV stock price reached its highest trading level at $4.8900 during the session, while it also had its lowest trading level at $4.2000.

Ratios:

To gain a deeper understanding of ELEV’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.99 and its Current Ratio is at 12.99. In the meantime, Its Debt-to-Equity ratio is 0.48 whereas as Long-Term Debt/Eq ratio is at 0.48.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, JMP Securities on March 01, 2024, initiated with a Mkt Outperform rating and assigned the stock a target price of $7.

On May 30, 2023, SVB Securities Upgraded its rating to Outperform which previously was Market Perform and also upped its target price recommendation from $5 to $8.

On December 23, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $12.H.C. Wainwright initiated its Buy rating on December 23, 2021, with a $12 target price.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ELEV now has a Market Capitalization of 227.69M and an Enterprise Value of 174.72M.

Stock Price History:

Over the past 52 weeks, ELEV has reached a high of $5.89, while it has fallen to a 52-week low of $0.36. The 50-Day Moving Average of the stock is 2.4811, while the 200-Day Moving Average is calculated to be 1.4710.

Shares Statistics:

It appears that ELEV traded 2.93M shares on average per day over the past three months and 1.41M shares per day over the past ten days. A total of 42.41M shares are outstanding, with a floating share count of 34.72M. Insiders hold about 18.15% of the company’s shares, while institutions hold 75.90% stake in the company. Shares short for ELEV as of Feb 15, 2024 were 4.01M with a Short Ratio of 1.37, compared to 1.8M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 9.46% and a Short% of Float of 10.70%.

Earnings Estimates

As of right now, 5 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.24 for the current quarter, with a high estimate of -$0.1 and a low estimate of -$0.29, while EPS last year was -$0.82. The consensus estimate for the next quarter is -$0.29, with high estimates of -$0.27 and low estimates of -$0.32.

Analysts are recommending an EPS of between -$1.43 and -$1.51 for the fiscal current year, implying an average EPS of -$1.46. EPS for the following year is -$1.21, with 5 analysts recommending between -$1.16 and -$1.35.

Most Popular

[the_ad id="945"]